Mackenzie Financial Corp Boosts Position in Maximus, Inc. (MMS)

Mackenzie Financial Corp increased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 18.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,159,102 shares of the health services provider’s stock after purchasing an additional 182,494 shares during the quarter. Mackenzie Financial Corp owned 1.79% of Maximus worth $74,762,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of MMS. Janus Henderson Group PLC increased its stake in Maximus by 718.8% during the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after purchasing an additional 1,941,521 shares in the last quarter. Koch Industries Inc. bought a new stake in Maximus during the 2nd quarter worth approximately $629,000. FMR LLC increased its stake in Maximus by 10.4% during the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after purchasing an additional 438,025 shares in the last quarter. Victory Capital Management Inc. increased its stake in Maximus by 13.3% during the 3rd quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock worth $226,667,000 after purchasing an additional 413,325 shares in the last quarter. Finally, Trilogy Global Advisors LP bought a new position in shares of Maximus during the 2nd quarter worth approximately $17,325,000. 94.82% of the stock is owned by institutional investors and hedge funds.

MMS has been the subject of several research reports. Zacks Investment Research cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Robert W. Baird reaffirmed a “hold” rating and set a $64.00 price target on shares of Maximus in a research note on Friday, September 1st. Finally, Canaccord Genuity decreased their price target on shares of Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research note on Friday, November 10th. Two investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $64.33.

Shares of Maximus, Inc. (NYSE:MMS) traded down $0.41 on Tuesday, hitting $68.77. 375,100 shares of the stock traded hands, compared to its average volume of 358,619. The company has a market cap of $4,506.15, a PE ratio of 22.24, a P/E/G ratio of 2.60 and a beta of 1.35. Maximus, Inc. has a one year low of $51.74 and a one year high of $70.43.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were paid a dividend of $0.045 per share. The ex-dividend date was Tuesday, November 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.26%. Maximus’s dividend payout ratio is currently 5.66%.

In other news, Director Raymond B. Ruddy sold 25,000 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $62.68, for a total value of $1,567,000.00. Following the completion of the sale, the director now owns 227,552 shares of the company’s stock, valued at approximately $14,262,959.36. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, General Counsel David Francis sold 1,373 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $65.35, for a total value of $89,725.55. Following the completion of the sale, the general counsel now directly owns 13,617 shares of the company’s stock, valued at approximately $889,870.95. The disclosure for this sale can be found here. Insiders have sold a total of 83,717 shares of company stock valued at $5,421,835 over the last ninety days. Company insiders own 3.10% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Mackenzie Financial Corp Boosts Position in Maximus, Inc. (MMS)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/05/mackenzie-financial-corp-boosts-position-in-maximus-inc-mms.html.

Maximus Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

What are top analysts saying about Maximus Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Maximus Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit